More on ATEC
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net loss | -25.57M |
| Depreciation and amortization | 10.4M |
| Stock-based compensation | 1.51M |
| Interest expense related to amortization of debt discount and debt issuance costs | 3.32M |
| Provision for doubtful accounts | -53K |
| Provision for excess and obsolete inventory | 4.49M |
| Gain on sale of IMC Co. (discontinued operations) | |
| Deferred income tax benefit | 0 |
| Accounts receivable | 10.66M |
| Inventories | -4.72M |
| Prepaid expenses and other current assets | 1.8M |
| Other assets | 191K |
| Accounts payable | -5.25M |
| Accrued expenses and other | 233K |
| Deferred revenues | |
| Net cash provided by (used in) operating activities | |
| Cash received in acquisition of Scient'x | |
| Proceeds from sale of IMC Co. (discontinued operations) | 69.89M |
| Cash paid for acquisition of Brazilian subsidiary | |
| Purchases of property and equipment | -7.29M |
| Purchase of intangible assets | |
| Net cash used in investing activities | |
| Exercise of stock options | |
| Net proceeds from issuance of common stock | |
| Borrowings under lines of credit | 94.24M |
| Repayments under lines of credit | -110.84M |
| Principal payments on capital lease obligations | -606K |
| Principal payments on notes payable | -53.82M |
| Net cash (used in) provided by financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | -1.22M |
| Net (decrease) increase in cash and cash equivalents | 14.65M |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Cash paid for interest | 6.12M |
| Cash paid for income taxes | 920K |
| Purchases of property and equipment in accounts payable | 543K |
| Financing of software and support by third party | |
| Financing of insurance premiums by insurance provider | |
| Payable for acquisition of Brazilian subsidiary | |
| Non-cash purchases of license agreements | |
| Issuance of common stock in connection with Scient'x acquisition | |
| Stock options issued in connection with Scient'x acquisition | |
| Non-cash exercise of warrants | |
Entities mentioned with ATEC
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- S3 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
